Inventor · disambiguated record
Yong Peng
Also filed as: PENG YONG · PENG YONG YI
21 granted patents·1 pending application·95 citations·filing 2012–2020
92Inventor score
Files withCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD10CENTAURUS BIOPHARMA CO LTD6COMMW SCIENT IND RES ORG2BEIJING SHENOGEN PHARMA GROUP LTD1COMMONWEALTH SCIENT AND INDUSTRIAL RESEARCH ORGANIZATION1
Top patents by PatentIndex Score
22 records- 0192US9725439B2Quinazoline derivative and preparation method thereforCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2014·Granted Aug 8, 2017·13 cites·16 claims
- 0290US9926299B2Inhibitors of bruton's tyrosine kinaseCENTAURUS BIOPHARMA CO LTD·Filed 2013·Granted Mar 27, 2018·33 cites·9 claims
- 0385US10155793B2Modified bacterial collagen-like proteinsCOMMW SCIENT IND RES ORG·Filed 2014·Granted Dec 18, 2018·8 cites·11 claims
- 0485US10053501B2Purification of triple helical proteinsCOMMONWEALTH SCIENT AND INDUSTRIAL RESEARCH ORGANIZATION·Filed 2014·Granted Aug 21, 2018·8 cites·25 claims
- 0585US9309211B2Arylalkene derivatives and use thereof as selective estrogen receptor modulatorsCENTAURUS BIOPHARMA CO LTD·Filed 2012·Granted Apr 12, 2016·11 cites·6 claims
- 0683US10561657B2Pyrrolopyrimidine compoundCENTAURUS BIOPHARMA CO LTD·Filed 2015·Granted Feb 18, 2020·3 cites·19 claims
- 0782US9550781B2Kinase modulating compounds, compositions containing the same and use thereofCENTAURUS BIOPHARMA CO LTD·Filed 2012·Granted Jan 24, 2017·9 cites·14 claims
- 0881US10112922B2Inhibitor of bruton's tyrosine kinaseCENTAURUS BIOPHARMA CO LTD·Filed 2015·Granted Oct 30, 2018·4 cites·8 claims
- 0979US10745383B21,3,5-triazine derivative and method of using sameCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Aug 18, 2020·2 cites·15 claims
- 1073US9708295B2Substituted 2-aminopyridine protein kinase inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2014·Granted Jul 18, 2017·3 cites·17 claims
- 1170US10570141B2Substituted pyrrolopyrimidine CDK inhibitor, pharmaceutical composition containing same and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Feb 25, 2020·1 cites·20 claims
- 1255US10329277B2N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(3-methyl-2-OXO-2,3-dihydro-1h-benzo[d]imidazol-1-yl)pyrimidin-2-yl)amino)phenyl)acrylamide hydrochloride as an inhibitor of epidermal growth factor receptor activityCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Jun 25, 2019·0 cites·7 claims
- 1352US11608534B2Methods of detecting an EML4-ALK fusion tumor biomarkerUNIV SICHUAN·Filed 2020·Granted Mar 21, 2023·0 cites·1 claims
- 1449US12209074B2SHP2 phosphatase allosteric inhibitorBEIJING SHENOGEN PHARMA GROUP LTD·Filed 2020·Granted Jan 28, 2025·0 cites·8 claims
- 1546US9394348B2Collagen-like silk genesCOMMW SCIENT IND RES ORG·Filed 2012·Granted Jul 19, 2016·0 cites·28 claims
- 1645US10155775B2Substituted amino six-membered saturated heteroalicycles as long-acting DPP-IV inhibitorsCENTAURUS BIOPHARMA CO LTD·Filed 2016·Granted Dec 18, 2018·0 cites·19 claims
- 1744US11203586B2Iridinesulfonamide compound and use method thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Dec 21, 2021·0 cites·16 claims
- 1843US9458170B2Compound of camptothecin and preparation and use thereofLI YULIANG·Filed 2013·Granted Oct 4, 2016·0 cites·4 claims
- 1942US11111240B2Sultam compound and application method thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Sep 7, 2021·0 cites·20 claims
- 2040US10155722B2Antitumor compound targeting IDH2 mutation and method of use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Dec 18, 2018·0 cites·20 claims
- 2139US10829492B2Amino pyrazolopyrimidine compound used as neurotrophic factor tyrosine kinase receptor inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Nov 10, 2020·0 cites·20 claims
- 2235US2019040063A1Tricyclic compound for bromodomain-containing protein inhibitor and preparation pharmaceutical composition, and application thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →